Pasithea Therapeutics logo

Pasithea Therapeutics

KTTA | NASDAQ
Chart Builder DCF Calculator
$0.50
-$0.01 (-2.67%)
At close: Sep 25, 2026, 4:00 PM ET
-2.67%

Rating

Updated: Sep 18, 2026
32.8
Fundamentals Weak
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $16.68M
1D Range
0.49 0.51
52W Range
0.28 2.06

Valuation (TTM)

PE -0.20
PB 0.33
EV/EBITDA 1,958.94

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $3.00
Loading financial charts...

Profile

Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its ...

Sector Healthcare
Industry Biotechnology
Employees 5
IPO Date Sep 15, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$3.00
Upside
+500.00%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.